RNASET2 and ovarian cancer: Collectively, these data strongly suggested that RNASET2 expression in both ovarian cancer cell models is associated with a less aggressive tumor phenotype in terms of cell proliferation, with inhibition of ECM-dependent src kinase activation as a plausible underlying mechanism [28].